SCHEMBL23949030

SCHEMBL23949030

c1ccc(-n2c3ccccc3c3c2ccc2c4c5c(ccc4n(-c4ccccc4)c23)c2ccncc2n2c3cnccc3nc52)cc1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AOC3 Q16853 3/20 0.33
CDK4 P11802 2/20 0.31
CDK6 Q00534 2/20 0.31
PDE2A O00408 1/20 0.30
PDE4D Q08499 1/20 0.30
PDE11A Q9HCR9 1/20 0.30
PDE10A Q9Y233 1/20 0.30
DYRK1A Q13627 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23948398 0.96 KDM4E (0.36) KDM4EATML3MBTL1AOC3PDE2A
SCHEMBL23948330 0.93 ATM (0.35) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL23948404 0.93 AOC3 (0.33) KDM4EATML3MBTL1AOC3PDE2A
SCHEMBL23948262 0.87 KDM4E (0.37) KDM4EATML3MBTL1AOC3CDK4
SCHEMBL15436385 0.81 KDM4E (0.49) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL24290639 0.81 KDM4E (0.40) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL23948633 0.81 KDM4E (0.35) KDM4EATML3MBTL1AOC3CDK4
SCHEMBL23948871 0.81 KDM4E (0.37) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL21890204 0.80 KDM4E (0.47) KDM4EATML3MBTL1ALDH1A1LMNA
SCHEMBL23948717 0.80 KDM4E (0.39) KDM4EATML3MBTL1AOC3PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323963-A1 Functional Materials Based on Stable Chemical Structure TEAD4, TEAD2, TEAD1 KDM4E 2817/4885ATM 2872/4885L3MBTL1 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.